James C Garbutt

UNCCH, School of Medicine, Psychiatry

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Patents
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network

James C Garbutt

• Organizations
  University of North Carolina at Chapel Hill
  
  School of Medicine
  
  Psychiatry
  
  

Help us refine your profile

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  Lisa Berger; Michael Fisher; Michael Brondino; Michael Bohn; Robert Gwyther; Lance Longo; Nicole Beier; Amy Ford; Joe Greco; James C. Garbutt

  Efficacy of Acamprosate for Alcohol Dependence in a Family Medicine Setting in the United States: A Randomized, Double-Blind, Placebo-Controlled Study

  Alcoholism: Clinical and Experimental Research. 2013;37(4):668-674.
  0

• 2.

  2013

  Cort A. Pedersen; Kelly L. Smedley; Jane Leserman; Lars Fredrik Jarskog; Shane W. Rau; Alexei Kampov-Polevoi; Robin L. Casey; Trace Fender; James C. Garbutt

  Intranasal Oxytocin Blocks Alcohol Withdrawal in Human Subjects

  Alcoholism: Clinical and Experimental Research. 2013;37(3):484-489.
  0

• 3.

  2013

  Richard H. Nguyen; Cody Gillen; J.C. Garbutt; Alexei Kampov-Polevoi; Jameson K. Holden; Eric M. Francisco; Mark Tommerdahl

  Centrally-mediated sensory information processing is impacted with increased alcohol consumption in college-aged individuals

  Brain Research. 2013;1492:53-62.
  0

• 4.

  2012

  Daniel E. Jonas; James C. Garbutt; Halle R. Amick; Janice M. Brown; Kimberly A. Brownley; Carol L. Council; Anthony J. Viera; Tania M. Wilkins; Cody J. Schwartz; Emily M. Richmond; et al.

  Behavioral counseling after screening for alcohol misuse in primary care: A systematic review and meta-analysis for the U.S. preventive services task force

  Annals of Internal Medicine. 2012;157(9):645-654.
  3

• 5.

  2011

  James C. Garbutt; Alexei Kampov-Polevoy; Robert Gallop; Linda Kalka-Juhl

  Response to Ameisen

  Alcoholism: Clinical and Experimental Research. 2011;35(5):847-847.
  0

• 6.

  2010

  James C. Garbutt; Alexei B. Kampov-Polevoy; Robert Gallop; Linda Kalka-Juhl; Barbara A. Flannery

  Efficacy and safety of baclofen for alcohol dependence: A randomized, double-blind, placebo-controlled trial

  Alcoholism: Clinical and Experimental Research. 2010;34(11):1849-1857.
  45

• 7.

  2010

  Gabriel S. Dichter; Moria J. Smoski; Alexey B. Kampov-Polevoy; Robert Gallop; James C. Garbutt

  Unipolar depression does not moderate responses to the sweet taste test

  Depression and Anxiety. 2010;27(9):859-863.
  8

• 8.

  2010

  Leslie A. Lange; Alexey B. Kampov-Polevoy; James C. Garbutt

  Sweet liking and high novelty seeking: Independent phenotypes associated with alcohol-related problems

  Alcohol and Alcoholism. 2010;45(5):431-436.
  8

• 9.

  2010

  Lorenzo Leggio; James C. Garbutt; Giovanni Addolorato

  Effectiveness and safety of baclofen in the treatment of alcohol dependent patients

  CNS and Neurological Disorders - Drug Targets. 2010;9(1):33-44.
  29

• 10.

  2010

  James C. Garbutt

  Efficacy and tolerability of naltrexone in the management of alcohol dependence

  Current Pharmaceutical Design. 2010;16(19):2091-2097.
  22

• 11.

  2009

  James C Garbutt

  The state of pharmacotherapy for the treatment of alcohol dependence.

  Journal of substance abuse treatment. 2009;36(1):S15-23; quiz S24-25.
  45

• 12.

  2009

  James C. Garbutt; Michael Osborne; Robert Gallop; John Barkenbus; Kathy Grace; Meghan Cody; Barbara Flannery; Alexey B. Kampov-Polevoy

  Treatment: Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence

  Alcohol and Alcoholism. 2009;44(3):293-300.
  14

• 13.

  2007

  James C Garbutt; Barbara Flannery

  Baclofen for alcoholism

  Lancet. 2007;370(9603):1884-1885.
  9

• 14.

  2007

  Stephanie S. O'Malley; James C. Garbutt; David R. Gastfriend; Qunming Dong; Henry R. Kranzler

  Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment

  Journal of Clinical Psychopharmacology. 2007;27(5):507-512.
  42

• 15.

  2007

  David R. Gastfriend; James C. Garbutt; Helen M. Pettinati; Robert F. Forman

  Reduction in heavy drinking as a treatment outcome in alcohol dependence

  Journal of Substance Abuse Treatment. 2007;33(1):71-80.
  20

• 16.

  2007

  Blair U. Bradford; Jennifer Karnitsching; Linda L. Powell; James C. Garbutt

  Rates of ethanol metabolism decrease in sons of alcoholics following a priming dose of ethanol

  Alcohol. 2007;41(4):263-270.
  1

• 17.

  2006

  James C. Garbutt

  Medications for the treatment of alcohol dependence

  American Family Physician. 2006;74(11):1836-1837.
  1

• 18.

  2006

  Alexey B. Kampov-Polevoy; Arthur Alterman; Elena Khalitov; James C. Garbutt

  Sweet preference predicts mood altering effect of and impaired control over eating sweet foods

  Eating Behaviors. 2006;7(3):181-187.
  18

• 19.

  2006

  James C. Garbutt

  New therapeutic options for alcohol dependence: Long-acting intramuscular formulations of naltrexone

  Journal of Clinical Psychiatry. 2006;67(SUPPL. 14):30-34.
  2

• 20.

  2006

  James C. Garbutt

  Emerging pharmacologic treatments for alcohol dependence

  Journal of Clinical Psychiatry. 2006;67(SUPPL. 14):35-40.
  3

• 21.

  2005

  Michael Golding; Michael Kotlyar; Stanley W. Carson; Sherri Hoyler; Cindy Lazarus; Colin Davidson; Joseph Guzzo; Eric Sontz; J.C. Garbutt

  Effects of paroxetine on cardiovascular response to mental stress in subjects with a history of coronary artery disease and no psychiatric diagnoses

  Psychopharmacology. 2005;182(3):321-326.
  11

• 22.

  2005

  Olivier Ameisen; James C. Garbutt; Henry R. Kranzler; Stephanie S. O'Malley; David R. Gastfriend; Bernard L. Silverman; John W. Loewy; Elliot W. Ehrich; Helen M. Pettinati

  Naltrexone treatment for alcohol dependency [3] (multiple letters)

  Journal of the American Medical Association. 2005;294(8):899-900.
  8

• 23.

  2005

  James C. Garbutt; Henry R. Kranzler; Stephanie S. O'Malley; David R. Gastfriend; Helen M. Pettinati; Bernard L. Silverman; John W. Loewy; Elliot W. Ehrich

  Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: A randomized controlled trial

  Journal of the American Medical Association. 2005;293(13):1617-1625.
  224

• 24.

  2004

  Barbara A. Flannery; James C. Garbutt; Meghan W. Cody; William Renn; Kathy Grace; Michael Osborne; Ken Crosby; Mary Morreale; Amy Trivette

  Baclofen for alcohol dependence: A preliminary open-label study

  Alcoholism: Clinical and Experimental Research. 2004;28(10):1517-1523.
  83

• 25.

  2004

  Raymond F. Anton; Helen Pettinati; Allen Zweben; Henry R. Kranzler; Bankole Johnson; Michael J. Bohn; Mary E. McCaul; Robert Anthenelli; Ihsan Salloum; et al.

  A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence

  Journal of Clinical Psychopharmacology. 2004;24(4):421-428.
  32

• 26.

  2003

  Alexey B. Kampov-Polevoy; James C. Garbutt; Elena Khalitov

  Family History of Alcoholism and Response to Sweets

  Alcoholism: Clinical and Experimental Research. 2003;27(11):1743-1749.
  34

• 27.

  2002

  Michael Golding; Michael Kotlyar; James C. Garbutt; Joseph Guzzo; Eric Sontz; Alan Hinderliter; Stanley W. Carson

  Paroxetine modulates psychological and sympathetic responses during public speaking [6]

  Journal of Clinical Psychopharmacology. 2002;22(1):98-99.
  10

• 28.

  2002

  Robert N Golden; Amy Durr Heine; R.David Ekstrom; Joseph M Bebchuk; Martha E Leatherman; James C Garbutt

  A longitudinal study of serotonergic function in depression

  Neuropsychopharmacology. 2002;26(5):653-659.
  11

• 29.

  2001

  J.C. Garbutt; S.L. West; T.S. Carey; K.N. Lohr; F.T. Crews

  Les médicaments pour renforcer l'abstinence après le sevrage alcoolique sont-ils efficaces ?

  Revue du Praticien - Medecine Generale. 2001;15(542):1328-1329.
  0

• 30.

  1999

  James C. Garbutt; Suzanne L. West; Timothy S. Carey; Kathleen N. Lohr; Fulton T. Crews

  Pharmacological treatment: Of alcohol dependence - A review of the evidence

  Journal of the American Medical Association. 1999;281(14):1318-1325.
  288

• 31.

  1999

  S.L. West; J.C. Garbutt; T.S. Carey; L.J. Lux; A.M. Jackman; S. Tolleson-Rinehart; K.N. Lohr; F.T. Crews

  Pharmacotherapy for alcohol dependence.

  Evidence report/technology assessment (Summary). 1999;(3):1-5.
  3

• 32.

  1999

  Alexey B. Kampov-Polevoy; James C. Garbutt; David S. Janowsky

  Association between preference for sweets and excessive alcohol intake: A review of animal and human studies

  Alcohol and Alcoholism. 1999;34(3):386-395.
  117

• 33.

  1998

  Alexey B. Kampov-Polevoy; James C. Garbutt; C.E. Davis; David S. Janowsky

  Preference for higher sugar concentrations and Tridimensional Personality Questionnaire scores in alcoholic and nonalcoholic men

  Alcoholism: Clinical and Experimental Research. 1998;22(3):610-614.
  35

• 34.

  1997

  A.R. Hirsch; A. Kampov-Polevoy; J.C. Garbutt; D. Janowsky

  High sucrose preference in alcoholic men [11] (multiple letters)

  American Journal of Psychiatry. 1997;154(11):1631-1632.
  6

• 35.

  1997

  Amir H. Rezvani; James C. Garbutt; David H. Overstreet; Li Li; Cheryl H. Walker; Y. Yang; George A. Mason

  Thyrotropin releasing hormone analog TA-0910 suppresses alcohol intake in alcohol drinking african green monkeys

  Alcoholism: Clinical and Experimental Research. 1997;21(2):261-266.
  11

• 36.

  1997

  Alexey Kampov-Polevoy; James C. Garbutt; David Janowsky

  Evidence of preference for a high-concentration sucrose solution in alcoholic men

  American Journal of Psychiatry. 1997;154(2):269-270.
  92

• 37.

  1997

  George A. Mason; Amir H. Rezvani; David H. Overstreet; Mani Hamedi; Cheryl H. Walker; Ying Yang; James C. Garbutt

  Involvement of dopamine D₂ receptors in the suppressive effect of the thyrotropin-releasing hormone analog TA-0910 on alcohol intake in alcohol- preferring rats

  Alcoholism: Clinical and Experimental Research. 1997;21(9):1623-1629.
  10

• 38.

  1996

  George A. Mason; Amir H. Rezvani; David H. Overstreet; James C. Garbutt

  Thyrotropin-releasing hormone analog TA-0910 reduces voluntary alcohol intake of P rats subchronically in a limited scheduled access paradigm

  Alcoholism: Clinical and Experimental Research. 1996;20(6):1000-1003.
  8

• 39.

  1996

  James C. Garbutt; James P. Mayo; Karley Y. Little; Gregory M. Gillette; George A. Mason; Bess Dew; Arthur J. Prange Jr.

  Dose-response studies with thyrotropin-releasing hormone: Evidence for differential pituitary responses in men with major depression, alcoholism, or no psychopathology

  Alcoholism: Clinical and Experimental Research. 1996;20(4):717-722.
  10

• 40.

  1995

  James C. Garbutt; Linda P. Miller; Gerald Kramer; Lori L. Davis; George A. Mason; Arthur J. Prange Jr.; Frederick Petty

  Increased serum γ-aminobutyric acid (GABA) levels in young men at high-risk for alcoholism

  Biological Psychiatry. 1995;38(10):704-706.
  2

• 41.

  1995

  J.C. Garbutt; L.P. Miller; L. Mundle; M. Senger; G.A. Mason

  Thyrotropin and prolactin responses to thyrotropin-releasing hormone in young men at high or low risk for alcoholism

  Alcoholism: Clinical and Experimental Research. 1995;19(5):1133-1140.
  6

• 42.

  1994

  James C. Garbutt; James P. Mayo; Karley Y. Little; Gregory M. Gillette; George A. Mason; Bess Dew; Arthur J. Prange Jr.

  Dose-response studies with protirelin

  Archives of General Psychiatry. 1994;51(11):875-883.
  19

• 43.

  1994

  J.C. Garbutt; L.P. Miller; J.S. Karnitschnig; G.A. Mason

  Thyrotropin response to thyrotropin-releasing hormone in young men at high or low risk for alcoholism

  Annals of the New York Academy of Sciences. 1994;708:129-133.
  1

• 44.

  1994

  G.A. Mason; A.H. Rezvani; D.R. Grady; J.C. Garbutt

  The subchronic effects of the TRH analog TA-0910 and bromocriptine on alcohol preference in alcohol-preferring rats: Development of tolerance and cross-tolerance

  Alcoholism: Clinical and Experimental Research. 1994;18(5):1196-1201.
  19

• 45.

  1993

  Linda R. Noonan; Cheryl H. Walker; Li Li; James C. Garbutt; Arthur J. Prange Jr.; George A. Mason

  Effects of thyroid state on preference for and sensitivity to ethanol in Fischer-344 rats

  Progress in Neuropsychopharmacology and Biological Psychiatry. 1993;17(3):475-486.
  1

• 46.

  1993

  M. Maes; M.H. Corrigan; J.C. Garbutt; D. Quade

  TRH test and suicide [2]

  Biological Psychiatry. 1993;34(7):503-504.
  0

• 47.

  1993

  Mark H. Corrigan; J.C. Garbutt; Dana Quade

  Response

  Biological Psychiatry. 1993;34(7):503-504.
  0

• 48.

  1992

  M.H.N. Corrigan; G.M. Gillette; D. Quade; J.C. Garbutt

  Panic, suicide, and agitation: Independent correlates of the TSH response to TRH in depression

  Biological Psychiatry. 1992;31(10):984-992.
  11

• 49.

  1992

  J.C. Garbutt; J. McDavid; G.A. Mason; D. Quade; P.T. Loosen

  Evidence for normal feedback inhibition of triiodothyronine on the thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) in abstinent male alcoholics

  Alcoholism: Clinical and Experimental Research. 1992;16(5):881-883.
  3

• 50.

  1992

  R.N. Golden; D. Ekstrom; T.M. Brown; R. Ruegg; D.L. Evans; J.J. Haggerty Jr.; J.C. Garbutt; C.A. Pedersen; G.A. Mason; et al.

  Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects

  American Journal of Psychiatry. 1992;149(9):1168-1175.
  42

• 51.

  1992

  G.A. Mason; L.R. Noonan; J.C. Garbutt; J.D. Caldwell; K. Shimoda; C.H. Walker; L. Li; A.J. Prange Jr.

  Effects of ethanol and control liquid diets on the hypothalamic- pituitary-thyroid axis of male Fischer-344 rats

  Alcoholism: Clinical and Experimental Research. 1992;16(6):1130-1137.
  8

• 52.

  1992

  A.H. Rezvani; J.C. Garbutt; K. Shimoda; P.L. Garges; D.S. Janowsky; G.A. Mason

  Attenuation of alcohol preference in alcohol-preferring rats by a novel TRH analogue, TA-0910

  Alcoholism: Clinical and Experimental Research. 1992;16(2):326-330.
  20

• 53.

  1991

  James C. Garbutt; James P. Mayo Jr.; George A. Mason; Dana Quade; Peter T. Loosen; Arthur J. Prange Jr.

  Interpretation of the thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH): Implications of an improved TSH assay system

  Biological Psychiatry. 1991;29(7):718-720.
  2

• 54.

  1991

  Kazutaka Shimoda; George A. Mason; Cheryl H. Walker; James C. Garbutt; Arthur J. Prange Jr.

  Administration of chlordiazepoxide affects [³H][3-MeHis²]thyrotropin-releasing hormone binding in rat brain

  Peptides. 1991;12(1):199-202.
  1

• 55.

  1991

  J.C. Garbutt; R.E. Hicks; C.J. Clayton; R.T. Andrews; G.A. Mason

  Behavioral and endocrine interactions between thyrotropin-releasing hormone and ethanol in normal human subjects

  Alcoholism: Clinical and Experimental Research. 1991;15(6):1045-1049.
  1

• 56.

  1991

  J.A. Wainer; J.C. Garbutt; G.M. Gillette; G.A. Mason; D. Quade

  Failure of chlordiazepoxide to antagonize the thyrotropin or prolactin response to thyrotropin-releasing hormone in humans

  Neuroendocrinology Letters. 1991;13(6):431-436.
  1

• 57.

  1991

  R.N. Golden; J.H. Gilmore; M.H.N. Corrigan; R.D. Ekstrom; B.T. Knight; J.C. Garbutt

  Serotonin, suicide, and aggression: Clinical studies

  Journal of Clinical Psychiatry. 1991;52(12 SUPPL.):61-69.
  32

• 58.

  1991

  J.C. Garbutt; J.P. Mayo Jr.; G.M. Gillette; K.Y. Little; R.E. Hicks; G.A. Mason; A.J. Prange Jr.

  Dose-response studies with thyrotropin-releasing hormone (TRH) in abstinent male alcoholics: Evidence for selective thyrotroph dysfunction?

  Journal of Studies on Alcohol. 1991;52(3):275-280.
  5

• 59.

  1990

  J.J. Haggerty Jr.; J.C. Garbutt; D.L. Evans; R.N. Golden; C. Pedersen; J.S. Simon; C.B. Nemeroff

  Subclinical hypothyroidism: A review of neuropsychiatric aspects

  International Journal of Psychiatry in Medicine. 1990;20(2):193-208.
  75

• 60.

  1990

  R.N. Golden; R. Ruegg; T.M. Brown; J. Haggerty Jr.; J.C. Garbutt; C.A. Pedersen; D.L. Evans

  Abnormal neuroendocrine responsivity to clomipramine in depression

  Psychopharmacology Bulletin. 1990;26(3):317-320.
  8

• 61.

  1989

  G.M. Gillette; J.C. Garbutt; D.E. Quade

  TSH response to TRH in depression with and without panic attacks

  American Journal of Psychiatry. 1989;146(6):743-748.
  9

• 62.

  1989

  J.C. Garbutt; G.M. Gillette; R.E. Hicks

  TRH modulates the neurobehavioral effects of chlordiazepoxide in humans. Preliminary observations

  Annals of the New York Academy of Sciences. 1989;553:585-587.
  0

• 63.

  1989

  J.C. Garbutt; G.M. Gillette; R.E. Hicks

  TRH effect on chlordiazepoxide sedation

  Biological Psychiatry. 1989;25(7):983-985.
  0

• 64.

  1988

  K.Y. Little; J.C. Garbutt; J.P. Mayo; G. Mason

  Lack of acute d-amphetamine effects on thyrotropin release

  Neuroendocrinology. 1988;48(3):304-307.
  0

• 65.

  1988

  K.Y. Little; J.C. Garbutt; J.P. Mayo

  Absence of acute stimulant effects after intravenous thyrotropin-releasing hormone (TRH) in man: Comparison to d-amphetamine

  Human Psychopharmacology. 1988;3(3):213-216.
  0

• 66.

  1988

  J.C. Garbutt; G.M. Gillette

  Apparent complex partial seizure in a bipolar patient after withdrawal of carbamazepine

  Journal of Clinical Psychiatry. 1988;49(10):410-411.
  6

• 67.

  1987

  J.C. Garbutt

  Potentiation of propoxyphene by phenelzine.

  American Journal of Psychiatry. 1987;144(2):251-252.
  0

• 68.

  1987

  A.J. Prange Jr.; J.C. Garbutt; P.T. Loosen; G. Bissette; C.B. Nemeroff

  The role of peptides in affective disorders: A review

  Progress in Brain Research. 1987;72:235-247.
  0

• 69.

  1987

  J.C. Garbutt; P.T. Loosen; M. Glenn

  Lack of effects of dopamine receptor blockade on the TSH response to TRH in borderline personality disorder

  Psychiatry Research. 1987;21(4):307-311.
  3

• 70.

  1987

  P.T. Loosen; J.C. Garbutt; A.J. Prange

  Evaluation of the diagnostic utility of the TRH-induced TSH response in psychiatric disorders

  Pharmacopsychiatry. 1987;20(3):90-95.
  10

• 71.

  1987

  P.T. Loosen; J.C. Garbutt; B. Dew; A.J. Prange

  Pituitary sensitivity to thyroid hormones in depressed patients

  Pharmacopsychiatry. 1987;20(3):85-89.
  3

• 72.

  1986

  John K. Hsiao; James C. Garbutt; Peter T. Loosen; George A. Mason; Arthur J. Prange Jr.

  Is there paradoxical growth hormone response to thyrotropin-releasing hormone in depression?

  Biological Psychiatry. 1986;21(7):595-600.
  2

• 73.

  1986

  J.C. Garbutt; J.P. Mayo Jr.; G.M. Gillette; K.Y. Little; G.A. Mason

  Lithium potentiation of tricyclic antidepressants following lack of T₃ potentiation

  American Journal of Psychiatry. 1986;143(8):1038-1039.
  8

• 74.

  1986

  P.T. Loosen; J.C. Garbutt; A. Tipermas

  The TRH test during dopamine receptor blockade in depressed patients

  Psychoneuroendocrinology. 1986;11(3):327-336.
  0

• 75.

  1986

  James C. Garbutt; Peter T. Loosen; Jill Blacharsh; Arthur J. Prange Jr.

  The prolactin response to thyrotropin-releasing hormone in depressed patients and normal subjects

  Psychoneuroendocrinology. 1986;11(2):213-219.
  3

• 76.

  1986

  D.L. Evans; S.K. Strawn; J.J. Haggerty Jr.; J.C. Garbutt; G.B. Burnett; C.A. Pedersen

  Appearance of mania in drug-resistant bipolar depressed patients after treatment with L-triiodothyronine

  Journal of Clinical Psychiatry. 1986;47(10):521-522.
  4

• 77.

  1985

  J.C. Garbutt; J.K. Hsiao; J.P. Mayo Jr.; J. Blacharsh

  A study of the TRH test in a family with psychiatric illness: A reflection on the TRH test as a state-trait marker

  Biological Psychiatry. 1985;20(5):570-572.
  1

• 78.

  1985

  J.C. Garbutt; D.S. Duch; C.A. Nichol; J.H. Woolf

  Urinary biopterin and neopterin excretion and pituitary-adrenal activity in psychiatric patients

  Psychiatry Research. 1985;16(3):181-187.
  5

• 79.

  1984

  David S. Duch; Jeffrey H. Woolf; Charles A. Nichol; Jonathan R. Davidson; James C. Garbutt

  Urinary excretion of bioterin and neopterin in psychiatric disorders

  Psychiatry Research. 1984;11(2):83-89.
  35

• 80.

  1984

  J.C. Garbutt; P.T. Loosen

  A dramatic behavioral response to thyrotropin-releasing hormone following low-dose neuroleptics

  Psychoneuroendocrinology. 1984;9(3):311-314.
  0

• 81.

  1983

  James C. Garbutt; Peter T. Loosen; Alan Tipermas; Arthur J. Prange Jr.

  The TRH test in patients with borderline personality disorder

  Psychiatry Research. 1983;9(2):107-113.
  13

• 82.

  1983

  I.C. Wilson; J.C. Garbutt; C.F. Lanier; J. Moylan; W. Nelson; A.J. Prange Jr.

  Is there a tardive dysmentia?

  Schizophrenia bulletin. 1983;9(2):187-192.
  3

• 83.

  1983

  J.C. Garbutt; D.P. Van Kammen

  The interaction between GABA and dopamine: Implications for schizophrenia

  Schizophrenia Bulletin. 1983;9(3):336-353.
  25

• 84.

  1983

  J.C. Garbutt; P.T. Loosen

  Is carbamazepine helpful in paroxysmal behavior disorders?

  American Journal of Psychiatry. 1983;140(10):1363-1364.
  4

• 85.

  1982

  James C. Garbutt; Daniel P. van Kammen; Robert A. Levine; David E. Sternberg; Dennis L. Murphy; James Ballenger; William E. Bunney Jr.; Walter M. Lovenberg

  Cerebrospinal fluid hydroxylase cofactor in schizophrenia

  Psychiatry Research. 1982;6(2):145-151.
  6

• 86.

  1979

  J. Garbutt; B. Malekpour; D. Brunswick; M.R. Jonnalagadda; L. Jolliff; R. Podolak; I. Wilson; A. Prange Jr.

  Effects of triiodothyronine on drug levels and cardiac function in depressed patients treated with imipramine

  American Journal of Psychiatry. 1979;136(7):980-982.
  10